drugset
drugset / Trial / NCT00235924

Study Assessing the Effects on Endometrium and Breast of Isoflavone in Post Menopausal Women

NCT00235924 ↗

Phase 3 Unknown 300 enrolled Laboratoires Arkopharma
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The main objective of this study is to determine the effects on the endometrium and breast of 70 mg daily dose of isoflavones.

Timeline

Start
2004-06
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Soy Isoflavone Unknown 70 mg —

Indications

No indication recorded.